{"organizations": [], "uuid": "f3ac9c6773b4885c473ad0dc5d3e1029268537af", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/sanofi-canada/brief-sanofi-to-invest-350-million-euros-in-canadian-vaccine-facility-idUSFWN1RP034", "country": "US", "domain_rank": 408, "title": "Healthcare group Sanofi to invest 350 mln euros in Canada vaccine facility", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-12T08:20:00.000+03:00", "replies_count": 0, "uuid": "f3ac9c6773b4885c473ad0dc5d3e1029268537af"}, "author": "", "url": "https://www.reuters.com/article/sanofi-canada/brief-sanofi-to-invest-350-million-euros-in-canadian-vaccine-facility-idUSFWN1RP034", "ord_in_thread": 0, "title": "Healthcare group Sanofi to invest 350 mln euros in Canada vaccine facility", "locations": [], "entities": {"persons": [{"name": "sudip kar-gupta", "sentiment": "none"}, {"name": "sunil nair", "sentiment": "none"}], "locations": [{"name": "canada", "sentiment": "none"}, {"name": "paris", "sentiment": "none"}, {"name": "ontario", "sentiment": "none"}, {"name": "toronto", "sentiment": "none"}], "organizations": [{"name": "sanofi", "sentiment": "negative"}, {"name": "healthcare", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "sanofi pasteur", "sentiment": "none"}, {"name": "ablynx", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 12, 2018 / 5:14 AM / in 4 minutes Healthcare group Sanofi to invest 350 mln euros in Canada vaccine facility Reuters Staff 1 Min Read \nPARIS, April 12 (Reuters) - French healthcare group Sanofi is investing 350 million euros ($432.4 million) in a Canadian vaccine facility, which the drugmaker said would help it meet growing demand in this area. \nSanofiâ€™s new investment will finance the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. \nThe new facility would allow its Sanofi Pasteur division to meet the growing demand of five-component acellular pertussis (5-acP) antigen, the company added. \nSanofi sealed two major takeovers at the start of 2018, buying haemophilia specialist Bioverativ for $11.6 billion and acquiring Ablynx, which is developing a prized experimental drug for a rare blood disorder, for 3.9 billion euros ($4.8 billion). $1 = 0.8094 euros Reporting by Sudip Kar-Gupta; Editing by Sunil Nair", "external_links": [], "published": "2018-04-12T08:20:00.000+03:00", "crawled": "2018-04-12T08:25:41.020+03:00", "highlightTitle": ""}